Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Don’t let arthritis become a pain this National Arthritis Week
  • USA - English


News provided by

Medical Specialists® Pharmacy

Oct 14, 2015, 08:30 ET

Share this article

Share toX

Share this article

Share toX


Bury, Lancashire (PRWEB UK) 14 October 2015 -- Monday 12 October happened to be both World Arthritis Day and the first day of National Arthritis Week 2015, which will be running until Sunday 18 October.

The awareness week is organised by the charity Arthritis Research UK and is used as an effective way to highlight the huge day-to-day impact that arthritis has for those with it, in addition to providing their friends and family, information to successfully manage the condition.

In the UK alone, there are an estimated 10 million people with arthritis. There are many different types of arthritis (such as ankylosing spondylitis, gout, lupus, etc.), but the two most common types of arthritis by far are...

Post this

As a long-term provider of a wide range of treatments for both osteoarthritis and rheumatoid arthritis such as brufen (ibuprofen), celebrex (celecoxib), diclofenac, naproxen, etc., at Medical Specialists® Pharmacy we are fully aware and sympathetic to arthritis sufferers; the pain associated with the condition can be excruciating, constant and cause otherwise ‘simple’ tasks in life, difficult to perform.

However, Arthritis Research UK want people to use National Arthritis Week as an opportunity to share their story to help boost awareness about what exactly it is like to live with the invisible pain of arthritis, in the hope that one day, people will be able to enjoy a life without pain.

In the UK alone, there are an estimated 10 million people with arthritis. There are many different types of arthritis (such as ankylosing spondylitis, gout, lupus, etc.), but the two most common types of arthritis by far are osteoarthritis and rheumatoid arthritis.

Osteoarthritis

Osteoarthritis afflicts 8 million people in the UK, making it the most common form of the condition. It is most prevalent in people over the age of 50 years of age, but can occur in younger people, following injury or another joint-related condition. The joints that are most commonly affected are those in the hands, hips, knees and spine.

Movement can prove difficult as osteoarthritis begins to impact the smooth cartilage lining of the join resulting in pain and stiffness. The cartilage can then thin, and tissues within the joint may become more active, causing swelling and the development of small bony spurs, called osteophytes. With osteoarthritis, the cartilage (connective tissue) between bones withers away, causing the bones to rub against one another.

Rheumatoid arthritis

Over 400,000 people are believed to suffer with rheumatoid arthritis in the UK. The condition tends to arise when a person is between the ages of 40 and 50, with women three times more likely to have it.

Rheumatoid and osteoarthritis differ due to the fact rheumatoid arthritis arises as the body's immune system impacts the affected joints, resulting in the pain and swelling.
The first area often affected is the outer covering (synovium) of the joint, before spreading across the joint, with the shape of the joint altered as the swelling increases. The bone and cartilage are then eroded. Those suffering with rheumatoid arthritis are also susceptible to other problems related to tissues and organs.

It is not just in Britain that the problem is prevalent though - arthritis and other types of musculoskeletal pain are in fact common, global problems that can impact any person irrespective of age (children can develop arthritis), sex, ethnicity or job.

Arthritis Research UK provide the funding for around 20 grants that have a combined value of about £6 million, dedicated to the research into understanding the cause of pain and attempting to develop new therapies and drugs to treat it.

Symptoms of arthritis

The symptoms of arthritis that people will experience can vary according to the specific type of arthritis he or she has, so therefore it is crucial to receive an accurate diagnosis if you suffer with one or more of the following symptoms:

• Difficult moving a joint.
• Fatigue.
• Inflammation in and around the joints.
• Joint pain, tenderness and stiffness.
• Muscle weakness.
• Poor sleep.
• Warm, red skin over the affected joint.
• Weight loss.

Treatment of arthritis

Unfortunately, there is no definitive/outright cure for arthritis, however health experts often recommend a good intake of omega 3 fats as they can prevent or subside symptoms, as the fats help to reduce inflammation. Moreover, Vitamin D – also known as “the sunshine vitamin” - can help to prevent rheumatoid arthritis. Excellent Vitamin D-containing foods include fatty fish such as mackerel, salmon and tuna. In addition, there are many arthritis treatments provided by Medical Specialists® that can be taken to slow down the condition.

For osteoarthritis, painkillers, non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, celebrex (celecoxib), diclofenac and brufen (ibuprofen), and corticosteroids, are usually prescribed. However, revolutionary osteoarthritis treatment flexiseq gel has also proved highly popular with patients of Medical Specialists® since the pharmacy started to provide it almost 2 years ago. The gel is remarkably free of any drug – meaning there are none of the side-effects of oral painkillers - and dries onto the skin, travelling into the affected joint(s) to reduce pain and restore mobility in the joint(s). Flexiseq gel may be particularly beneficial to those that don’t like to take tablets, or struggle to swallow them.

For the treatment of rheumatoid arthritis, the primary focus is limiting the progress of the condition as well as limiting the damage to the affected joints. The treatments usually include analgesics (painkillers), disease modifying anti-rheumatic drugs (DMARDs), regular exercise and physiotherapy.

David Bailey, Medical Specialists® Pharmacy, http://www.medical-specialists.co.uk, +44 161 762 9108, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.